Testing effectiveness (Phase 2)Study completedNCT02228460
What this trial is testing
Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-naïve Adult Male Patients With Fabry Disease
Who this might be right for
Fabry Disease
Genzyme, a Sanofi Company 11